Retatrutide 10mg / 20mg / 30mg / 40mg / 60mg
Investigational triple agonist targeting GLP-1, GIP and glucagon receptors — 10mg, 20mg, 30mg, 40mg and 60mg lyophilised vials at 99%+ purity for in vitro research.
Certificate of Analysis (COA)
Select a strength to view its Certificate of Analysis.
10 mg — View COA (Batch RET10-435)
20 mg — View COA (Batch RET20-374)
30 mg — View COA (Batch RET30-582)
40 mg — View COA (Batch RET40-961)
60 mg — View COA (Batch RET60-824)
Overview
Retatrutide (LY-3437943) is an investigational triple-receptor agonist that combines activity at the GLP-1, GIP and glucagon receptors in a single 39-residue peptide backbone. Supplied as a sterile lyophilised powder in 20mg, 30mg, 40mg and 60mg vials, each batch is verified to 99%+ purity by RP-HPLC and mass spectrometry.
Research
Retatrutide is used in vitro to study the combined pharmacology of incretin (GLP-1, GIP) and glucagon receptor signalling in a single molecule. Research groups compare it head-to-head against dual agonists (e.g. Tirzepatide) to characterise receptor bias, cAMP response, and peptide stability across long incubation windows.
Technical
| Peptide Type | Triple receptor agonist (GLP-1 / GIP / Glucagon) |
|---|---|
| Sequence length | 39 amino acids |
| Molecular weight | ≈4,731 Da |
| Form | Lyophilised powder |
| Quantity | 20mg, 30mg, 40mg or 60mg per vial |
| Purity | 99%+ by RP-HPLC + MS |
| Solubility | Water / bacteriostatic water |
| Research code | LY-3437943 |
Handling
Reconstitute with bacteriostatic water in a sterile environment; the fatty-acid modification gives Retatrutide a long in-solution stability profile relative to native GLP-1. Prepare working aliquots to minimise freeze-thaw cycles.
Storage
- Lyophilised vials: store below -18°C, protected from light.
- Reconstituted solution: refrigerate at 2–8°C.
- Avoid repeated freeze-thaw cycles to preserve peptide integrity.
Notice
- Strictly for laboratory research use only.
- Not for human or veterinary use.
- Not intended to diagnose, treat, cure, or prevent any condition.
FAQs
How does Retatrutide differ from Tirzepatide in research?
Retatrutide activates three receptors (GLP-1, GIP and glucagon), whereas Tirzepatide is a dual GLP-1 / GIP agonist. The added glucagon-receptor activity is the main mechanistic axis researchers compare in vitro.
What is the reported half-life of Retatrutide?
Published pharmacokinetic literature reports a half-life of approximately 6 days.
What purity is your Retatrutide?
Every vial is tested to 99%+ purity by RP-HPLC and confirmed by mass spectrometry (~4,731 Da). A batch-specific Certificate of Analysis is published on our COA page.
Which vial size should I choose — 20mg, 30mg or 40mg?
All three contain the same peptide at the same purity — the choice depends on how much working solution your study needs and cost per mg. The 40mg vial has the lowest cost per mg.
Do you ship Retatrutide from the UK?
Yes — all Retatrutide vials are UK-stocked with same-day Royal Mail Tracked 24 dispatch (order by 1pm, Mon-Fri).
Do you supply a Certificate of Analysis?
Yes — our tested batches have a third-party HPLC + MS COA linked from the product page.
You Might Also Like…
-
AOD-9604 10mg
£53.99 -
Bacteriostatic Water
Price range: £3.49 through £12.99 -
BPC-157
Price range: £16.99 through £29.99 -
Cagrilintide 5mg / 10mg
Price range: £28.99 through £56.99










